• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    More On HIK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Hikma Pharmaceuticals PLC (HIK.L)

    -LSE
    1,850.00 Down 25.00(1.33%) Feb 12, 11:35AM EST
    Prev Close:1,875.00
    Open:1,880.00
    Bid:1,849.00 x 8000
    Ask:1,851.00 x 2000000
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:1,822.00 - 1,893.00
    52wk Range:1,596.83 - 2,617.00
    Volume:519,098
    Avg Vol (3m):370,042
    Market Cap:3.69B
    P/E (ttm):15.23
    EPS (ttm):121.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Headlines

    » More Headlines for HIK.L

    Key Statistics

    Forward P/E (1 yr):13.12
    P/S (ttm):255.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.24
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback